SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
AMENDMENT TO APPLICATION OR REPORT
Pursuant to Section 12, 13 or 15(d) of the Securities Exchange Act of 1934
BIOMET, INC.
(Exact name of registrant as specified in its charter)
Indiana 0-12515 35-1418342
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
ofincorporation Identification No.)
or organization)
Airport Industrial Park, P.O. Box 587, Warsaw, Indiana 46581-0587
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (219) 267-6639
AMENDMENT NO. 1
The undersigned registrant hereby amends its response to Item 7, Financial
Statements and Exhibits, of its Current Report on Form 8-K, dated February 17,
1998, as set forth below:
Item 7. Financial Statements and Exhibits.
(a-b) No financial statements or pro forma financial information are
required to be filed as part of this report.
(c) See Index to Exhibits. The schedules and exhibits to the Joint Venture
Agreement filed as an Exhibit hereto are not included in reliance upon
Item 601(b)(2) of Regulation S-K. The undersigned registrant agrees to furnish
supplementally a copy of any omitted schedule or exhibit to the Commission upon
request.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this amendment to be signed on its behalf by the
undersigned, thereunto duly authorized.
BIOMET, INC.
By: /s/ Gregory D. Hartman
Gregory D. Hartman
Vice President, Finance
Dated: April 14, 1998
